These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1509106)

  • 1. Asymmetrical FDG-PET and MRI findings of striatonigral system in multiple system atrophy with hemiparkinsonism.
    Kato T; Kume A; Ito K; Tadokoro M; Takahashi A; Sakuma S
    Radiat Med; 1992; 10(3):87-93. PubMed ID: 1509106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and MRI correlation in multiple system atrophy].
    Negoro K; Morimatsu M
    No To Shinkei; 1994 May; 46(5):473-8. PubMed ID: 8060686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-field MR findings of multiple system atrophy].
    Tsuchiya K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jul; 50(7):772-9. PubMed ID: 2235325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnetic resonance imaging in multiple system atrophy].
    Aotsuka A; Shinotoh H; Hirayama K; Ikehira H; Hashimoto T
    Rinsho Shinkeigaku; 1992 Aug; 32(8):815-21. PubMed ID: 1490308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemi-parkinsonism in multiple system atrophy: a PET and MRI study.
    Kume A; Shiratori M; Takahashi A; Kato T; Ito K; Tadokoro M; Sakuma S
    J Neurol Sci; 1992 Jul; 110(1-2):37-45. PubMed ID: 1506867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of parkinsonism in multiple system atrophy: clinical and MRI correlation.
    Wakai M; Kume A; Takahashi A; Ando T; Hashizume Y
    Acta Neurol Scand; 1994 Oct; 90(4):225-31. PubMed ID: 7839806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
    Perani D; Bressi S; Testa D; Grassi F; Cortelli P; Gentrini S; Savoiardo M; Caraceni T; Fazio F
    Arch Neurol; 1995 Feb; 52(2):179-85. PubMed ID: 7848128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study.
    Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
    J Neurol Sci; 1996 Dec; 144(1-2):77-83. PubMed ID: 8994107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple system atrophy. Clinical and MR observations on 42 cases.
    Testa D; Savoiardo M; Fetoni V; Strada L; Palazzini E; Bertulezzi G; Girotti F
    Ital J Neurol Sci; 1993 Apr; 14(3):211-6. PubMed ID: 8314674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Speech disorders in olivopontocerebellar atrophy correlate with positron emission tomography findings.
    Kluin KJ; Gilman S; Markel DS; Koeppe RA; Rosenthal G; Junck L
    Ann Neurol; 1988 Jun; 23(6):547-54. PubMed ID: 3261572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy.
    Gilman S; Koeppe RA; Junck L; Kluin KJ; Lohman M; St Laurent RT
    Ann Neurol; 1994 Aug; 36(2):166-75. PubMed ID: 8053652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple system atrophy: a review of 203 pathologically proven cases.
    Wenning GK; Tison F; Ben Shlomo Y; Daniel SE; Quinn NP
    Mov Disord; 1997 Mar; 12(2):133-47. PubMed ID: 9087971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
    Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
    Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
    Lyoo CH; Jeong Y; Ryu YH; Lee SY; Song TJ; Lee JH; Rinne JO; Lee MS
    Brain; 2008 Feb; 131(Pt 2):438-46. PubMed ID: 18178568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple system atrophy (Shy-Drager syndrome): MR imaging.
    Pastakia B; Polinsky R; Di Chiro G; Simmons JT; Brown R; Wener L
    Radiology; 1986 May; 159(2):499-502. PubMed ID: 3961183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple system atrophy (MSA)].
    Moriwaka F; Tashiro K
    Nihon Rinsho; 1993 Nov; 51(11):2952-6. PubMed ID: 8277576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.
    Otsuka M; Kuwabara Y; Ichiya Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
    Ann Nucl Med; 1997 Aug; 11(3):251-7. PubMed ID: 9310175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal cell loss of the striatonigral system in multiple system atrophy.
    Kume A; Takahashi A; Hashizume Y
    J Neurol Sci; 1993 Jul; 117(1-2):33-40. PubMed ID: 8410064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy.
    Stocchi F; Carbone A; Inghilleri M; Monge A; Ruggieri S; Berardelli A; Manfredi M
    J Neurol Neurosurg Psychiatry; 1997 May; 62(5):507-11. PubMed ID: 9153611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.